LRA Highlights Groundbreaking Lupus Research at ACR Convergence 2023
This information is brought to you by the Lupus Research Alliance and Lupus Therapeutics and is not sponsored by, nor a part...
Accelerating Medicines Partnership
Lupus Nephritis: A Major Focus at the Lupus Research Alliance
Updated March, 2022
Developing safe and effective treatments for lupus nephritis has been an urgent and long-standing goal in the...
LRA Partnering with NIH, FNIH and Others on Groundbreaking Initiative
December 9, 2021
The Lupus Research Alliance (LRA) is proud and excited to partner again with the National Institutes of...
Good News on Lupus Nephritis Discoveries from ACR Convergence 2020
November 19, 2020
The LRA is proud to share the extraordinary work presented at ACR Convergence 2020 by research members...
LRA Highlights Full Continuum of Lupus Research at ACR Convergence 2020
30+ presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways
Results from...
Accelerating Medicines Partnership Completes Key Phase
September 24, 2019
The Accelerating Medicines Partnership (AMP) RA/Lupus Program, a joint effort involving the National Institutes of Health (NIH),...
LRA-Funded Researchers Present Cutting-Edge Science at FOCIS
July 11, 2019
The annual meeting of the Federation of Clinical Immunology Societies (FOCIS) is the key forum for translational...
NIH Work Co-Supported by LRA May Simplify Lupus Nephritis Monitoring
June 20, 2019
As reported by the National Institutes of Health (NIH), research published by the NIH Accelerating Medicines Partnership (AMP)...
Discovering Lupus Heterogeneity
May 22, 2019
Lupus is heterogeneous, meaning that symptoms are many and vary widely from patient to patient -- one...
Lupus Research Alliance Congratulates NIH on 5-Year AMP Success
February 28, 2019
NEW YORK, NY. As a co-sponsor of the National Institutes of Health (NIH) public-private Accelerating Medicines Partnership...
Promising Results from AMP
October 30, 2018
The Lupus Research Alliance is one of the sponsors of the Accelerating Medicines Partnership in Rheumatoid Arthritis...
Advancing Research Exponentially
August 14, 2018
Advancing Research Exponentially
An Update on AMP
by Jill Buyon, MD
Lupus nephritis (LN), one of the dreaded complications of...